You need to upgrade your Flash Player

ONCOLYTICS BIOTECH INC (ONCY) 2.70 red arrow -$0.09 (-3.23%) 07:17PM (15 mins delay)


Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet

Oct 12, 2009 - 9:05 PM EDT

Trading was a little thin due to the Columbus Day holiday Monday, and a breakdown in technical support levels caused some midsession panic, but the S&P 500 successfully logged its sixth straight gain- the best streak this year for the stock market. The Dow rose 20.86 to 9,885.80, but couldn't hold the intraday high for the year and the Nasdaq slipped 0.14 to 2,139.14.

In healthcare, DepoMed, Inc. (DEPO) was the biggest loser as shareholders watched the stock drop nearly 38% to $3.97 -2.39. Before the market opened, DepoMed announced top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.


Complete Story »

Source: Seeking Alpha (Oct 12, 2009 - 9:05 PM EDT)



Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.